Loss of A, B, and H antigens in oral cancer

Inmunologia

Volumn 27, Issue 3, 2008, Pages 127-131

  Biondi, Claudia ^a   Campi, C ^a   Escovich, L ^a   Garcia Borras S ^a   Racca, A ^a   Cotorruelo, C ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

ABO blood group antigens; Oral cancer; Oral precancer

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; BLOOD GROUP H ANTIGEN;

ANTIGEN EXPRESSION; BLOOD GROUP ABO SYSTEM; CANCER INVASION; CANCER STAGING; CARCINOMA CELL; CONTROL GROUP; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; PRECANCER; REVIEW;

EID: 77956017617     PISSN: 02139626     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0213-9626(08)70060-X     Document Type: Review

References (21)

1. Hakomori S. Aberrant glycosylation in tumor and tumor associated carbohydrate antigens. Adv Can Res 1989; 52:257-331.
2. Clausen H, Bennett EP, Grunnet N. Molecular genetics of ABO. Vox Sang 1994; 78(Suppl 2):91-103.
3. Bianco T, Farmer BJ, Sage RE, Dobrovic A. Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood 2001; 97: 3633-3639.
4. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: Their changes associated with human cancer. Biochim Biophys Acta 1999; 1473:247-266.
5. Hakomori S, Handa K. Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: Essential basis to define tumor malignancy. FEBS Letters 2002; 531:88-92. (Pubitemid 35232791)
6. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Moullac- Vaidye B, Clement M. ABH and Lewis histo-blood group antigens in cancer. Acta Pathol Microbiol Immunol Scand 2001; 109:9-31. (Pubitemid 32243471)
7. Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Liu CJ. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer. 2004; 109:230-237 (Pubitemid 38240925)
8. Hakomori S, Handa K. Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy. FEBS Letters 2002; 531:88-92. (Pubitemid 35232791)
9. Walkers J. American Association of Blood Banks. Manual técnico. 13th ed. Buenos Aires. Asociación Argentina de Hemoterapia e Inmunohematología. 2002.
10. Strauchen JA, Bergman SM, Hanson TAM. Expression of A and B Tissue Isoantigens in benign and malignant lesions of the Breast. Cancer 1998; 45: 2149-2155.
11. Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. Acta Pathol Microbiol Immunol Scand 2000; 108:1-28. (Pubitemid 30090251)
12. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1999; 1473:247-266.
13. Solís E, Provenzal O, Valverde J, Biondi C, Foresto P, Muller R, et al. Comparative study of the ABH antigenic expression between urothelium and buccal desquamation cells in patients with bladder carcinoma. Acta Urol Itál 1997; 11: 187-188. (Pubitemid 27341440)
14. Foresto P, Biondi C, Racca L, Brufman A, Yaber F, Solís E, et al. Glicosilación anormal de antígenos ABH solubles en patologías tumorales del tracto urinario. Arch Esp Urol 2000; 53: 196-199.
15. Boileau M , Cowles R, Schmidt K, Schmidt W. Comparison of specific red-cell adherence and immunoperoxidase staining techniques for ABO(H) blood-group cell-surface antigens on superficial transitional cell carcinoma of the bladder. J Surg Oncol 1985; 30: 72-79. (Pubitemid 16198302)
16. Gao S, Bennett EP, Reibel J, Chen XC, Christensen ME, Krogdahl A, et al. Histo-blood group ABO antigen in oral potentially malignant lesions and squamous cell carcinoma: Genotypic and phenotypic characterization. Acta Pathol Microbiol Immunol Scand 2004; 112:11-20. (Pubitemid 38297161)
17. Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Liu CJ. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer 2004; 109:230-237. (Pubitemid 38240925)
18. Santos-Garcia A, Abad-Hernandez MM, Fonseca-Sanchez E, Julian- Gonzalez R, Galindo-Villardon P, Cruz-Hernandez J. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2006; 11:E100-105.
19. Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. Acta Pathol Microbiol Immunol Scand 2000; 108:1-28. (Pubitemid 30090251)
20. Dabelsteen E, Roed-Petersen B, Pindborg JJ. Loss of epithelial blood group antigens A and B in oral premalignant lesions. Acta Pathol Microbiol Scand (A) 1975; 83:292-300.
21. Campi C, Escovich L, Valdés V, García-Borrás S, Racca L, Racca A, et al. Secretor status and ABH antigens expression in patients with oral lesions. Med Oral Patol Oral Cir Bucal 2007; 12:E431-E434.